Last reviewed · How we verify
Combination of Naproxen and Pregabalin — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Combination of Naproxen and Pregabalin (Combination of Naproxen and Pregabalin) — Xgene Pharmaceutical Group.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Combination of Naproxen and Pregabalin TARGET | Combination of Naproxen and Pregabalin | Xgene Pharmaceutical Group | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Combination of Naproxen and Pregabalin CI watch — RSS
- Combination of Naproxen and Pregabalin CI watch — Atom
- Combination of Naproxen and Pregabalin CI watch — JSON
- Combination of Naproxen and Pregabalin alone — RSS
Cite this brief
Drug Landscape (2026). Combination of Naproxen and Pregabalin — Competitive Intelligence Brief. https://druglandscape.com/ci/combination-of-naproxen-and-pregabalin. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab